Complications After CT-guided Lung Biopsies at St. Olavs Hospital
KELSO
1 other identifier
observational
1,200
0 countries
N/A
Brief Summary
At St. Olavs Hospital, a prospective collection of data on complications related to CT-guided lung biopsies has been conducted over several years as part of quality control study. The primary aim of this quality control study is to map complications in all patients who have undergone percutaneous CT-guided lung biopsy at St. Olavs Hospital from May 2012 to December 2023.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2012
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
April 7, 2026
CompletedFirst Posted
Study publicly available on registry
April 14, 2026
CompletedApril 14, 2026
April 1, 2026
11.7 years
April 7, 2026
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pneumothorax
The frequency of pneumothorax after lung biopsy
Patients are assessed with a CT scan 5 minutes after the lung biopsy
Lung bleeding
How frequent is parenchymal bleeding after lung biopsy
Patiens are assessed with a CT scan 5 minutes after the procedure
Secondary Outcomes (1)
Factors associated with complications after lung biopsy
All patiens are assessed with CT scan 5 minutes after the lung biopsy
Study Arms (1)
CT-guided lung biopsy
All patient with a lung nodule eligible for CT-guided needle biopsy
Interventions
This is a simple needle biopsy of lung nodules guided with CT imaging
Eligibility Criteria
1200
You may qualify if:
- All patients eligible to a CT-guided needle biopsy of a lung nodule (allcomers)
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Hajjar WM, Fetyani IM, Alqarni RM, Alajlan FA, Bahgat FF, Alharbi SR. Complications and Risk Factors of Patients Undergoing Computed Tomography-Guided Core Needle Lung Biopsy: A Single-Center Experience. Cureus. 2021 Aug 5;13(8):e16907. doi: 10.7759/cureus.16907. eCollection 2021 Aug.
PMID: 34513480BACKGROUNDHeerink WJ, de Bock GH, de Jonge GJ, Groen HJ, Vliegenthart R, Oudkerk M. Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. Eur Radiol. 2017 Jan;27(1):138-148. doi: 10.1007/s00330-016-4357-8. Epub 2016 Apr 23.
PMID: 27108299BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1200 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2026
First Posted
April 14, 2026
Study Start
May 1, 2012
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share